EBR Systems is dedicated to superior treatment of cardiac rhythm disease by providing more physiologically effective stimulation through wireless endocardial pacing. The company's patented, proprietary technology was developed to eliminate the need for cardiac pacing leads, historically the major source of complications and reliability issues in cardiac rhythm disease management. The Company's initial product eliminates the need for coronary sinus leads to stimulate the left ventricle in heart failure patients requiring CRT. Future products will address wireless endocardial stimulation for bradycardia, and other non-cardiac indications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/08/15 | $20,000,000 |
Delphi Ventures Emergent Medical Partners Split Rock Partners St. Paul Venture Capital Stephen Mahle Thomas Fogarty | undisclosed | |
| 11/15/17 | $50,000,000 |
Ascension Health Ventures Brandon Capital Partners  Emergent Medical Partners M. H. Carnegie & Co. Split Rock Partners | undisclosed | |
| 08/27/19 | $30,000,000 | Venture |
Brandon Capital Partners Emergent Medical Partners M. H. Carnegie & Co. Split Rock Partners | undisclosed |
